[Effect and mechanism of ubiquitin-like protein FAT10 on Anginduced endothelial cell inflammation]

Zhonghua Xin Xue Guan Bing Za Zhi. 2023 Nov 24;51(11):1181-1187. doi: 10.3760/cma.j.cn112148-20230824-00106.
[Article in Chinese]

Abstract

Objective: To investigate the role and related mechanism of ubiquitin-like protein FAT10 in the angiotensin Ⅱ (AngⅡ)-induced endothelial cell inflammatory responses. Methods: The Western blot was used to detect the protein expression of FAT10 in 16-weeks old WKY rat carotid artery, thoracic aorta artery, renal artery and vascular smooth muscle cells (VSMC), human umbilical vein endothelial cells (HUVEC) and human breast cancer cells (MDA-MB-231). The optimal concentration and stimulation time of AngⅡ on inducing the highest FAT10 in HUVEC were determined. The following plasmids were constructed: control plasmid, overexpression FAT10 plasmid (Flag-FAT10), invalid interference plasmid, and interference FAT10 plasmid (sh-FAT10). These plasmids were then transfected into HUVEC cells and divided into following groups: control group, Flag-FAT10 group, invalid interference group, and sh-FAT10 group. After culturing with 100 nmol/L AngⅡ for 36 h, the control group and the Flag-FAT10 group were treated with reactive oxygen species scavenger N-acetyl-L-cysteine ​​(NAC), the protein expression levels of the inflammatory factor monocyte chemotactic protein-1 (MCP-1) and tumor necrosis factor-α (TNF-α) were measured. Laser confocal microscopy was used to detect the generation levels of reactive oxygen species in the cells of vrious groups. Results: FAT10 was expressed in carotid artery, thoracic aorta, and renal artery of normal blood pressure rats and expressed in HUVEC, VSMC, MDA-MB-231. The expression level of FAT10 gradually increased in proportion to the increase of the time and concentration of AngⅡ stimulation in HUVEC, and the expression level of FAT10 was the highest when the HUVEC was treated with 100 nmol/L AngⅡ for 36 h (P<0.01). The protein expression level of MCP-1 (P<0.001) and TNF-α (P<0.01) was higher in AngⅡ treated HUVEC with FAT10 overexpression, while the expression level of MCP-1 and TNF-α protein was lower in AngⅡ treated HUVEC with FAT10 knockdown (all P<0.01). The level of intracellular reactive oxygen species (ROS) production was significantly increased with FAT10 overexpression (P<0.001), and the level of ROS was decreased when the expression of FAT10 was interfered (P<0.05). The increased level of MCP-1 and TNF-α proteins in FAT10 overexpressed HUVEC was reversed by NAC (all P<0.05). Conclusion: FAT10 promotes the release of inflammatory factors induced by AngⅡ in endothelial cells by increasing the level of intracellular ROS production.

目的: 探究类泛素蛋白FAT10对血管紧张素Ⅱ(AngⅡ)诱导的血管内皮炎症因子释放的作用机制。 方法: 选取雄性16周龄WKY大鼠3只和人脐静脉内皮细胞(HUVEC)、人乳腺癌细胞(MDA-MB-231)、人血管平滑肌细胞(VSMC)。使用Western blot检测大鼠胸主动脉、颈动脉、肾动脉以及上述细胞中FAT10的表达。使用HUVEC细胞筛选FAT10表达量最高时AngⅡ的浓度及作用时间。构建空白对照质粒、过表达FAT10质粒、无效干扰质粒及干扰FAT10质粒,使用上述质粒转染HUVEC细胞。在加入100 nmol/L AngⅡ培养36 h后,采用Western blot 检测炎症因子单核细胞趋向性蛋白-1(MCP-1)、肿瘤坏死因子-α(TNF-α)的蛋白表达水平;采用激光共聚焦显微镜检测细胞内活性氧生成水平;对转染空白对照质粒和过表达FAT10质粒的细胞应用活性氧清除剂N-乙酰基-L-半胱氨酸(NAC),采用Western blot检测应用或不应用NAC时MCP-1、TNF-α蛋白的表达水平。 结果: FAT10在正常血压大鼠的颈动脉、胸主动脉、肾动脉以及HUVEC、VSMC、MDA-MB-231细胞系中均有表达。在HUVEC中,随着AngⅡ作用时间及浓度增加,FAT10的表达量逐渐增高,且在100 nmol/L AngⅡ作用36 h时达最高(P<0.01)。在AngⅡ诱导下,过表达FAT10的HUVEC中炎症因子MCP-1(P<0.001)与TNF-α的蛋白表达显著增加(P<0.01),干扰FAT10的HUVEC中MCP-1与TNF-α的蛋白表达降低(P均<0.001)。过表达FAT10的HUVEC中活性氧生成水平增加(P<0.001),干扰FAT10的HUVEC中活性氧生成水平降低(P<0.05)。应用NAC后,过表达FAT10的HUVEC中炎症因子MCP-1与TNF-α的蛋白表达升高趋势被逆转(P均<0.05)。 结论: FAT10通过增加细胞内活性氧生成水平而促进AngⅡ诱导的内皮细胞炎症因子释放。.

Publication types

  • English Abstract

MeSH terms

  • Angiotensin II* / metabolism
  • Angiotensin II* / pharmacology
  • Animals
  • Cells, Cultured
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Inflammation
  • Rats
  • Rats, Inbred WKY
  • Reactive Oxygen Species / metabolism
  • Reactive Oxygen Species / pharmacology
  • Tumor Necrosis Factor-alpha* / metabolism
  • Tumor Necrosis Factor-alpha* / pharmacology
  • Ubiquitins / metabolism
  • Ubiquitins / pharmacology

Substances

  • Reactive Oxygen Species
  • Angiotensin II
  • Tumor Necrosis Factor-alpha
  • Ubiquitins